Skip to content
10-Q

Quarterly Report

LENZ THERAPEUTICS, INC. LENZ

0001815776-26-000037

← back to feed
Filed
May 11, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 5, 2026 31.35M sh
Shares Diluted Q1 2026 · Mar 31, 2026 31.35M sh
Shares Diluted Q1 2026 · Mar 31, 2025 27.53M sh
Capex Q1 2026 · Mar 31, 2026 $18K
Capex Q1 2026 · Mar 31, 2025 $110K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$33.58M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$16.05M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $24.77M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $25.18M
Stockholders Equity Q1 2026 · Mar 31, 2026 $246.49M
Stockholders Equity Q1 2026 · Dec 31, 2025 $284.34M
Stockholders Equity Q1 2026 · Mar 31, 2025 $192.01M
Stockholders Equity Q1 2026 · Dec 31, 2024 $204.08M
Current Liabilities Q1 2026 · Mar 31, 2026 $25.81M
Current Liabilities Q1 2026 · Dec 31, 2025 $21.19M
Total Liabilities Q1 2026 · Mar 31, 2026 $26.04M
Total Liabilities Q1 2026 · Dec 31, 2025 $21.54M
Current Assets Q1 2026 · Mar 31, 2026 $268.37M
Current Assets Q1 2026 · Dec 31, 2025 $301.41M
Total Assets Q1 2026 · Mar 31, 2026 $272.54M
Total Assets Q1 2026 · Dec 31, 2025 $305.88M
Eps Diluted Q1 2026 · Mar 31, 2026 −$1.32
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.53
Eps Basic Q1 2026 · Mar 31, 2026 −$1.32
Eps Basic Q1 2026 · Mar 31, 2025 −$0.53
Sga Expense Q1 2026 · Mar 31, 2026 $44.96M
Sga Expense Q1 2026 · Mar 31, 2025 $11.11M
Rd Expense Q1 2026 · Mar 31, 2026 $0
Rd Expense Q1 2026 · Mar 31, 2025 $5.82M
Net Income Q1 2026 · Mar 31, 2026 −$41.49M
Net Income Q1 2026 · Mar 31, 2025 −$14.62M
Operating Income Q1 2026 · Mar 31, 2026 −$44.14M
Operating Income Q1 2026 · Mar 31, 2025 −$16.93M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $1.08M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $0
Revenue Q1 2026 · Mar 31, 2026 $1.9M
Revenue Q1 2026 · Mar 31, 2025 $0